Neoleukin Therapeutics, Inc. (NLTX)

Last Year

08-Jul-21 -- 07-Jul-22

Time Period:

$933.55K Net Amount

Buy:	$933.55K	$6.11 - $6.45
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

10

0

1

+1

0

+2

1

+3

Two Year Chart

08-Jul-20 -- 07-Jul-22

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Feb-22 10:00 PM View:	26-Oct-21 Gift 0	Drachman Jonathan G President and CEO Director		Neoleukin Therapeutics, Inc. - NLTX	7% 2.25M to 2.4M	$933.55K 7%	0	$6.11 - $6.45	--	Show Txns Hide Txns

03-May-22 7:16 PM View:	02-May-22 Option Sale ($6.75K)	Patel Priti Chief Medical Officer		Neoleukin Therapeutics, Inc. - NLTX	223% 2.0K to 6.46K	0	0	--	--	Show Txns Hide Txns